Division of Pediatric Nephrology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.
Curr Opin Pediatr. 2019 Apr;31(2):232-236. doi: 10.1097/MOP.0000000000000740.
Kidney transplantation is the preferred treatment modality for children with end-stage renal disease. In this review, we discuss the factors affecting the selection of the appropriate donor to ensure the best possible short and long-term outcomes.
Outcomes of pediatric renal transplantation from living donors are superior to those obtained from deceased donors. Despite this, the rate of living donor kidney transplantation has declined over the last decade. Living donation is considered to be safe but long-term outcomes, especially for parents who are often young donors, are not well understood. Living donation can also cause a financial impact to the donor and family. Barriers to living donation must be sought and defeated. Deceased donor organs are now the primary source of kidneys. How the risk of extended time on dialysis must be weighed against the improved outcomes that may accrue from better matching is controversial. Increasing the donor pool may be accomplished by reassessing sources that are currently avoided, such as donation after cardiac death and infant kidneys transplanted en bloc.
The pediatric nephrologist must balance waiting for the highest quality kidney against the need for the shortest possible waiting time.
肾移植是儿童终末期肾病的首选治疗方法。在这篇综述中,我们讨论了影响选择合适供体的因素,以确保获得最佳的短期和长期效果。
与来自已故供体的肾移植相比,来自活体供体的儿童肾移植的结果更优。尽管如此,活体供肾移植的比例在过去十年中有所下降。活体捐赠被认为是安全的,但长期结果,特别是对于通常是年轻供体的父母,还不是很清楚。活体捐赠也会对供体及其家庭造成经济影响。必须寻求并克服活体捐赠的障碍。已故供体器官现在是肾脏的主要来源。如何权衡延长透析时间的风险与可能因更好的匹配而获得的改善结果,这是有争议的。通过重新评估目前被回避的供体来源,如心脏死亡后捐献和整块移植婴儿肾脏,可能会增加供体库。
儿科肾脏病医生必须在等待质量最高的肾脏和最短等待时间之间取得平衡。